-
April 10, 2013
Ongoing revenue growth struggles and eroding market share is making the deep-value case harder at AngioDynamics.
-
February 04, 2013
AngioDynamics Inc. (ANGO), a provider of therapeutic and diagnostic devices for the treatment of peripheral vascular ...
-
January 24, 2013
Consolidating its earlier partnership, AngioDynamics (ANGO) inked a definitive agreement to purchase certain assets ...
-
January 04, 2013
AngioDynamics Inc. (ANGO) reported adjusted earnings of 10 cents per share for the second quarter of fiscal 2013 ...
-
December 06, 2012
We have reiterated our Neutral rating on CR Bard Inc. (BCR) following its third quarter results with a price target ...
-
October 19, 2012
Leading medical devices maker C.R. Bard (BCR) is scheduled to report its second quarter fiscal 2012 results after ...
-
October 17, 2012
Provider of therapeutic and diagnostic devices to treat peripheral vascular and other non-coronary diseases, ...
-
October 11, 2012
Therapeutic and diagnostic devices maker AngioDynamics (ANGO) recently won a contract with HealthTrust Purchasing ...
-
October 09, 2012
AngioDynamics Inc. (ANGO) reported first-quarter fiscal 2013 (ended August 31) adjusted earnings of 10 cents per ...
-
September 28, 2012
Merit Medical Systems, Inc. (MMSI), a medical device company, recently obtained the clearance of the U.S. Food and ...
-
September 04, 2012
Therapeutic and diagnostic devices maker, AngioDynamics Inc. (ANGO) recently received 510(k) approval from the U.S. ...
-
August 23, 2012
We have reiterated our Neutral rating on CR Bard Inc. (BCR) following its second quarter results, where adjusted ...
-
July 13, 2012
AngioDynamics (ANGO) reported fourth-quarter fiscal 2012 (ended May 31) adjusted earnings of 10 cents per share ...
-
July 10, 2012
BSD Medical Corporation (BSDM), a leader in providing medical systems for treatment of cancer and other invasive ...
-
July 06, 2012
AngioDynamics Inc. (ANGO), a therapeutic and diagnostic devices maker, achieved a milestone for its tumor-zapping ...
-
June 14, 2012
Medical technologies and devices major, CR Bard Inc. (BCR) raised its quarterly dividend by 5% to 20 cents per ...
-
October 11, 2011
With a new CEO, a strong balance sheet, and good technology, investors might want to check out AngioDynamics. The ...
-
July 29, 2011
A high valuation magnifies a bump in Bard's growth.
-
June 14, 2011
AngioDynamics is shaking things up in the hopes of rekindling growth.
-
October 20, 2008
St. Jude is going to face tougher competition in the core CRM business, but that shouldn't alter the basic "growth ...
